JCR’s pipeline encompasses recombinant DNA based hormones and enzymes for the treatment of Infertility, Fabry Disease, Hunter Syndrome, Renal anemia, Gaucher Disease, and Growth Disorder. It has subsidiaries in Japan, China, and Switzerland. JCR is headquartered in Ashiya, Hyogo, Japan. Еще